{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:16Z","timestamp":1791247936907,"version":"4.1.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573713"],"award-info":[{"award-number":["82573713"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202501ZYTS114"],"award-info":[{"award-number":["YDZJ202501ZYTS114"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The central nervous system (CNS) has long been considered immune privilege due to the blood-brain barrier, lack of traditional lymphatic drainage, and unique immune microenvironment. However, recent neuroimmunology research has demonstrated that the CNS maintains continuous communication with the peripheral immune system via meningeal lymphatic vessels, lymphoid systems, and border-associated macrophages. This paradigm shift has brought tertiary lymphoid structures (TLSs), ectopic lymphoid aggregates induced by chronic inflammation, infection, or tumors, into focus as key players in neuroimmune interactions. TLSs exert a dual effect in neuroinflammation. In infectious diseases like viral encephalitis, they promote local antibody production and T cell responses, aiding pathogen clearance. In contrast, in multiple sclerosis, autoimmune encephalitis, Alzheimer\u2019s disease, and Parkinson\u2019s disease, TLSs may sustain chronic inflammation, drive autoantibody production, and accelerate neurodegeneration. This review systematically summarizes the composition, induction mechanisms, and functional heterogeneity of TLSs across neurological diseases. We discuss their protective versus pathogenic roles in neuroinflammation and highlight their diagnostic value and therapeutic potential, aiming to provide new insights for precision intervention in neuroimmunological disorders.<\/jats:p>","DOI":"10.1186\/s12974-026-03961-6","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:44:40Z","timestamp":1783687480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tertiary lymphoid structures in neuroinflammation coordinate neuroimmune homeostasis and pathological progression"],"prefix":"10.1186","volume":"23","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3961_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/WCO.0000000000000454","volume":"30","author":"C Meyer","year":"2017","unstructured":"Meyer C, Martin-Blondel G, Liblau RS. Endothelial cells and lymphatics at the interface between the immune and central nervous systems: implications for multiple sclerosis. Curr Opin Neurol. 2017;30:222\u201330.","journal-title":"Curr Opin Neurol"},{"key":"3961_CR2","doi-asserted-by":"publisher","unstructured":"Toader C, Tataru CP, Munteanu O, Covache-Busuioc RA, Serban M, Ciurea AV, et al. Revolutionizing neuroimmunology: unraveling immune dynamics and therapeutic innovations in CNS disorders. Int J Mol Sci. 2024;25(24):13614. https:\/\/doi.org\/10.3390\/ijms252413614.","DOI":"10.3390\/ijms252413614"},{"key":"3961_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41577-025-01175-0","volume":"25","author":"LCD Smyth","year":"2025","unstructured":"Smyth LCD, Kipnis J. Redefining CNS immune privilege. Nat Rev Immunol. 2025;25:766\u201375.","journal-title":"Nat Rev Immunol"},{"key":"3961_CR4","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1177\/0271678X221098145","volume":"42","author":"G Li","year":"2022","unstructured":"Li G, Cao Y, Tang X, Huang J, Cai L, Zhou L. The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders. J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism. 2022;42:1364\u201382.","journal-title":"J Cereb blood flow metabolism: official J Int Soc Cereb Blood Flow Metabolism"},{"key":"3961_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","volume":"27","author":"XB Ding","year":"2021","unstructured":"Ding XB, Wang XX, Xia DH, Liu H, Tian HY, Fu Y, et al. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease. Nat Med. 2021;27:411\u20138.","journal-title":"Nat Med"},{"key":"3961_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","volume":"10","author":"Z Xu","year":"2015","unstructured":"Xu Z, Xiao N, Chen Y, Huang H, Marshall C, Gao J, et al. Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain Abeta accumulation and memory deficits. Mol neurodegeneration. 2015;10:58.","journal-title":"Mol neurodegeneration"},{"key":"3961_CR7","doi-asserted-by":"publisher","unstructured":"Hiraki C, Tsuruta F. The Meninges as CNS Interfaces and the Roles of Meningeal Macrophages. Biomolecules. 2025;15(4):497. https:\/\/doi.org\/10.3390\/biom15040497.","DOI":"10.3390\/biom15040497"},{"key":"3961_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10571-025-01598-2","volume":"45","author":"J Pan","year":"2025","unstructured":"Pan J, Fu Y, Yang P, Li W, Luo Z, Zhang A, et al. The cerebral lymphatic system: function, controversies, and therapeutic approaches for central nervous system diseases. Cell Mol Neurobiol. 2025;45:80.","journal-title":"Cell Mol Neurobiol"},{"key":"3961_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.it.2024.03.007","volume":"45","author":"S Da Mesquita","year":"2024","unstructured":"Da Mesquita S, Rua R. Brain border-associated macrophages: common denominators in infection, aging, and Alzheimer\u2019s disease? Trends Immunol. 2024;45:346\u201357.","journal-title":"Trends Immunol"},{"key":"3961_CR10","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","volume":"126","author":"AW Lund","year":"2016","unstructured":"Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Investig. 2016;126:3389\u2013402.","journal-title":"J Clin Investig"},{"key":"3961_CR11","doi-asserted-by":"publisher","first-page":"45789","DOI":"10.18632\/oncotarget.9953","volume":"7","author":"ES Steinskog","year":"2016","unstructured":"Steinskog ES, Sagstad SJ, Wagner M, Karlsen TV, Yang N, Markhus CE, et al. Impaired lymphatic function accelerates cancer growth. Oncotarget. 2016;7:45789\u2013802.","journal-title":"Oncotarget"},{"key":"3961_CR12","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.ajpath.2019.06.010","volume":"189","author":"M Wagner","year":"2019","unstructured":"Wagner M, Steinskog ES, Wiig H. Blockade of lymphangiogenesis shapes tumor-promoting adipose tissue inflammation. Am J Pathol. 2019;189:2102\u201314.","journal-title":"Am J Pathol"},{"key":"3961_CR13","doi-asserted-by":"publisher","unstructured":"Kim ME, Lee JS. Mechanisms and emerging regulators of neuroinflammation: exploring new therapeutic strategies for neurological disorders. Curr Issues Mol Biol. 2024;47(1):8. https:\/\/doi.org\/10.3390\/cimb47010008.","DOI":"10.3390\/cimb47010008"},{"key":"3961_CR14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/glia.70007","volume":"73","author":"LK Festa","year":"2025","unstructured":"Festa LK, Jordan-Sciutto KL, Grinspan JB. Neuroinflammation: An Oligodendrocentric View. Glia. 2025;73:1113\u201329.","journal-title":"Glia"},{"key":"3961_CR15","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1347987.","journal-title":"Front Aging Neurosci"},{"key":"3961_CR16","doi-asserted-by":"publisher","unstructured":"Muller L, Di Benedetto S, Muller V. From Homeostasis to neuroinflammation: insights into cellular and molecular interactions and network dynamics. Cells. 2025;14(1):54. https:\/\/doi.org\/10.3390\/cells14010054.","DOI":"10.3390\/cells14010054"},{"key":"3961_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","volume":"19","author":"Y Sato","year":"2023","unstructured":"Sato Y, Silina K, van den Broek M, Hirahara K, Yanagita M. The roles of tertiary lymphoid structures in chronic diseases. Nat Rev Nephrol. 2023;19:525\u201337.","journal-title":"Nat Rev Nephrol"},{"key":"3961_CR18","doi-asserted-by":"publisher","first-page":"102288","DOI":"10.1016\/j.tice.2023.102288","volume":"86","author":"D Ribatti","year":"2024","unstructured":"Ribatti D. Tertiary lymphoid structures, a historical reappraisal. Tissue Cell. 2024;86:102288.","journal-title":"Tissue Cell"},{"key":"3961_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3892\/ol.2021.13097","volume":"22","author":"M Qin","year":"2021","unstructured":"Qin M, Jin Y, Pan LY. Tertiary lymphoid structure and B-cell-related pathways: A potential target in tumor immunotherapy. Oncol Lett. 2021;22:836.","journal-title":"Oncol Lett"},{"key":"3961_CR20","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","volume":"78","author":"K Silina","year":"2018","unstructured":"Silina K, Soltermann A, Attar FM, Casanova R, Uckeley ZM, Thut H, et al. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. Cancer Res. 2018;78:1308\u201320.","journal-title":"Cancer Res"},{"key":"3961_CR21","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","volume":"56","author":"WH Fridman","year":"2023","unstructured":"Fridman WH, Meylan M, Pupier G, Calvez A, Hernandez I, Sautes-Fridman C. Tertiary lymphoid structures and B cells: An intratumoral immunity cycle. Immunity. 2023;56:2254\u201369.","journal-title":"Immunity"},{"key":"3961_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z, et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct Target therapy. 2024;9:225.","journal-title":"Signal Transduct Target therapy"},{"key":"3961_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00262-025-04183-0","volume":"74","author":"C Tan","year":"2025","unstructured":"Tan C, Huang J, Gao N, Wu B, Juliet M, Xiao J, et al. Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent review. Cancer Immunol immunotherapy: CII. 2025;74:313.","journal-title":"Cancer Immunol immunotherapy: CII"},{"key":"3961_CR24","doi-asserted-by":"publisher","first-page":"216293","DOI":"10.1016\/j.canlet.2023.216293","volume":"568","author":"H Li","year":"2023","unstructured":"Li H, Ding JY, Zhang MJ, Yu HJ, Sun ZJ. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy. Cancer Lett. 2023;568:216293.","journal-title":"Cancer Lett"},{"key":"3961_CR25","doi-asserted-by":"publisher","first-page":"188799","DOI":"10.1016\/j.bbcan.2022.188799","volume":"1877","author":"B Wang","year":"2022","unstructured":"Wang B, Wang M, Ao D, Wei X. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer. Biochim et Biophys acta Reviews cancer. 2022;1877:188799.","journal-title":"Biochim et Biophys acta Reviews cancer"},{"key":"3961_CR26","doi-asserted-by":"publisher","first-page":"e70045","DOI":"10.1111\/imr.70045","volume":"332","author":"M Zuo","year":"2025","unstructured":"Zuo M, Wang AA, Gommerman JL. Follicle on the roof: tertiary lymphoid structures in central nervous system autoimmunity. Immunol Rev. 2025;332:e70045.","journal-title":"Immunol Rev"},{"key":"3961_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fimmu.2016.00451","volume":"7","author":"M Mitsdoerffer","year":"2016","unstructured":"Mitsdoerffer M, Peters A. Tertiary lymphoid organs in central nervous system autoimmunity. Front Immunol. 2016;7:451.","journal-title":"Front Immunol"},{"key":"3961_CR28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12967-025-06510-6","volume":"23","author":"J Chen","year":"2025","unstructured":"Chen J, Yang Y, Luan S, Xu W, Gao Y. Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression. J translational Med. 2025;23:528.","journal-title":"J translational Med"},{"key":"3961_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat reviews Neurol. 2021;17:157\u201372.","journal-title":"Nat reviews Neurol"},{"key":"3961_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","volume":"14","author":"B Serafini","year":"2004","unstructured":"Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004;14:164\u201374.","journal-title":"Brain Pathol"},{"key":"3961_CR31","doi-asserted-by":"publisher","unstructured":"Cohen M, Giladi A, Raposo C, Zada M, Li B, Ruckh J, et al. Meningeal lymphoid structures are activated under acute and chronic spinal cord pathologies. Life Sci alliance. 2021;4(1):e202000907. https:\/\/doi.org\/10.26508\/lsa.202000907.","DOI":"10.26508\/lsa.202000907"},{"key":"3961_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.immuni.2026.01.013","volume":"59","author":"D Chen","year":"2026","unstructured":"Chen D, Xu H. Meningeal B cells: Emerging players at the brain border. Immunity. 2026;59:244\u201356.","journal-title":"Immunity"},{"key":"3961_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41582-023-00838-7","volume":"19","author":"R Magliozzi","year":"2023","unstructured":"Magliozzi R, Howell OW, Calabrese M, Reynolds R. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis. Nat reviews Neurol. 2023;19:461\u201376.","journal-title":"Nat reviews Neurol"},{"key":"3961_CR34","doi-asserted-by":"publisher","unstructured":"Wang Y, Guo L, Yin X, McCarthy EC, Cheng MI, Hoang AT, et al. Pathogenic TNF-alpha drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity. Proc Natl Acad Sci USA. 2022;119(4):e2114406119. https:\/\/doi.org\/10.1073\/pnas.2114406119.","DOI":"10.1073\/pnas.2114406119"},{"key":"3961_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-60761-938-3_6","volume":"686","author":"A Weerasuriya","year":"2011","unstructured":"Weerasuriya A, Mizisin AP. The blood-nerve barrier: structure and functional significance. Methods Mol Biol. 2011;686:149\u201373.","journal-title":"Methods Mol Biol"},{"key":"3961_CR36","doi-asserted-by":"crossref","unstructured":"Malong L, Napoli I, Casal G, White IJ, Stierli S, Vaughan A et al. Characterization of the structure and control of the blood-nerve barrier identifies avenues for therapeutic delivery. Dev Cell. 2023;58:174\u2009\u2013\u200991e8.","DOI":"10.1016\/j.devcel.2023.01.002"},{"key":"3961_CR37","doi-asserted-by":"publisher","first-page":"113385","DOI":"10.1016\/j.expneurol.2020.113385","volume":"331","author":"EB Stubbs","year":"2020","unstructured":"Stubbs EB. Jr. Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies. Exp Neurol. 2020;331:113385.","journal-title":"Exp Neurol"},{"key":"3961_CR38","doi-asserted-by":"publisher","unstructured":"De Souza JM, Trevisan TJ, Sepresse SR, Londe AC, Franca Junior MC, Appenzeller S. Peripheral neuropathy in systemic autoimmune rheumatic diseases-diagnosis and treatment. Pharmaceuticals. 2023;16(4):587. https:\/\/doi.org\/10.3390\/ph16040587.","DOI":"10.3390\/ph16040587"},{"key":"3961_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-018-1259-5","volume":"15","author":"AK Mausberg","year":"2018","unstructured":"Mausberg AK, Szepanowski F, Odoardi F, Flugel A, Kleinschnitz C, Stettner M, et al. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis. J Neuroinflamm. 2018;15:217.","journal-title":"J Neuroinflamm"},{"key":"3961_CR40","doi-asserted-by":"publisher","unstructured":"Harrer C, Otto F, Radlberger RF, Moser T, Pilz G, Wipfler P, et al. The CXCL13\/CXCR5 immune axis in health and disease-implications for intrathecal B cell activities in neuroinflammation. Cells. 2022;11(17):2649. https:\/\/doi.org\/10.3390\/cells11172649.","DOI":"10.3390\/cells11172649"},{"key":"3961_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4049\/immunohorizons.1700062","volume":"2","author":"AR Masters","year":"2018","unstructured":"Masters AR, Jellison ER, Puddington L, Khanna KM, Haynes L. Attrition of T cell zone fibroblastic reticular cell number and function in aged spleens. ImmunoHorizons. 2018;2:155\u201363.","journal-title":"ImmunoHorizons"},{"key":"3961_CR42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1189\/jlb.2MR0815-380R","volume":"99","author":"MA Hauser","year":"2016","unstructured":"Hauser MA, Legler DF. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes. J Leukoc Biol. 2016;99:869\u201382.","journal-title":"J Leukoc Biol"},{"key":"3961_CR43","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/cmi.2017.13","volume":"14","author":"H Tang","year":"2017","unstructured":"Tang H, Zhu M, Qiao J, Fu YX. Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy. Cell Mol Immunol. 2017;14:809\u201318.","journal-title":"Cell Mol Immunol"},{"key":"3961_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5483\/BMBRep.2009.42.4.189","volume":"42","author":"I Evans","year":"2009","unstructured":"Evans I, Kim MY. Involvement of lymphoid inducer cells in the development of secondary and tertiary lymphoid structure. BMB Rep. 2009;42:189\u201393.","journal-title":"BMB Rep"},{"key":"3961_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2005.10.002","volume":"23","author":"JL Browning","year":"2005","unstructured":"Browning JL, Allaire N, Ngam-Ek A, Notidis E, Hunt J, Perrin S, et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity. 2005;23:539\u201350.","journal-title":"Immunity"},{"key":"3961_CR46","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki M, Zebboudj A, Yano H, Zhang SL, Payne G, Chandra AK, et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature. 2025;638:1076\u201384.","journal-title":"Nature"},{"key":"3961_CR47","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.trecan.2022.06.010","volume":"8","author":"M Wagner","year":"2022","unstructured":"Wagner M, Koyasu S. Cancer immunosurveillance by ILC2s. Trends cancer. 2022;8:792\u20134.","journal-title":"Trends cancer"},{"key":"3961_CR48","doi-asserted-by":"publisher","first-page":"e2451207","DOI":"10.1002\/eji.202451207","volume":"54","author":"AL Calvanese","year":"2024","unstructured":"Calvanese AL, Cecconi V, Staheli S, Schnepf D, Nater M, Pereira P, et al. Sustained innate interferon is an essential inducer of tertiary lymphoid structures. Eur J Immunol. 2024;54:e2451207.","journal-title":"Eur J Immunol"},{"key":"3961_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2023.04.008","volume":"111","author":"BD Hobson","year":"2023","unstructured":"Hobson BD, Stanley AT, De Los Santos MB, Culbertson B, Mosharov EV, Sims PA, et al. Conserved and cell type-specific transcriptional responses to IFN-gamma in the ventral midbrain. Brain Behav Immun. 2023;111:277\u201391.","journal-title":"Brain Behav Immun"},{"key":"3961_CR50","doi-asserted-by":"publisher","unstructured":"Zou J, Zhang Y, Zeng Y, Peng Y, Liu J, Xiao C, et al. Tertiary lymphoid structures: a potential biomarker for anti-cancer therapy. Cancers. 2022;14(23):5968. https:\/\/doi.org\/10.3390\/cancers14235968.","DOI":"10.3390\/cancers14235968"},{"key":"3961_CR51","doi-asserted-by":"publisher","unstructured":"Mattiuz R, Boumelha J, Hamon P, Le Berichel J, Vaidya A, Soong BY et al. Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer. bioRxiv: the preprint server for biology. 2024.12.27.628014. https:\/\/doi.org\/10.1101\/2024.12.27.628014","DOI":"10.1101\/2024.12.27.628014"},{"key":"3961_CR52","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.immuni.2021.05.012","volume":"54","author":"T Wu","year":"2021","unstructured":"Wu T, Wu L. Dendritic cell fate determination revealed by SISter assays. Immunity. 2021;54:1104\u20136.","journal-title":"Immunity"},{"key":"3961_CR53","doi-asserted-by":"publisher","first-page":"1538818","DOI":"10.3389\/fimmu.2025.1538818","volume":"16","author":"M Reste","year":"2025","unstructured":"Reste M, Ajazi K, Sayi-Yazgan A, Jankovic R, Bufan B, Brandau S, et al. Corrigendum: The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases. Front Immunol. 2025;16:1538818.","journal-title":"Front Immunol"},{"key":"3961_CR54","doi-asserted-by":"publisher","first-page":"696311","DOI":"10.3389\/fimmu.2021.696311","volume":"12","author":"M Dieude","year":"2021","unstructured":"Dieude M, Kaci I, Hebert MJ. The impact of programmed cell death on the formation of tertiary lymphoid structures. Front Immunol. 2021;12:696311.","journal-title":"Front Immunol"},{"key":"3961_CR55","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-012-1023-3","volume":"124","author":"S Kuerten","year":"2012","unstructured":"Kuerten S, Schickel A, Kerkloh C, Recks MS, Addicks K, Ruddle NH, et al. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Acta Neuropathol. 2012;124:861\u201373.","journal-title":"Acta Neuropathol"},{"key":"3961_CR56","doi-asserted-by":"publisher","first-page":"10859","DOI":"10.1073\/pnas.91.23.10859","volume":"91","author":"T Tsuchida","year":"1994","unstructured":"Tsuchida T, Parker KC, Turner RV, McFarland HF, Coligan JE, Biddison WE. Autoreactive CD8\u2009+\u2009T-cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci USA. 1994;91:10859\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3961_CR57","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1021\/acsnano.2c09619","volume":"17","author":"Z Wen","year":"2023","unstructured":"Wen Z, Liu H, Qiao D, Chen H, Li L, Yang Z, et al. Nanovaccines fostering tertiary lymphoid structure to attack mimicry nasopharyngeal carcinoma. ACS Nano. 2023;17:7194\u2013206.","journal-title":"ACS Nano"},{"key":"3961_CR58","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1007\/s12035-024-03937-8","volume":"61","author":"X Yang","year":"2024","unstructured":"Yang X, Jiang S, Liu F, Li Z, Liu W, Zhang X, et al. HCMV IE1\/IE1mut therapeutic vaccine induces tumor regression via intratumoral tertiary lymphoid structure formation and peripheral immunity activation in glioblastoma multiforme. Mol Neurobiol. 2024;61:5935\u201349.","journal-title":"Mol Neurobiol"},{"key":"3961_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-140491","volume":"5","author":"HE Allen Reish","year":"2015","unstructured":"Allen Reish HE, Standaert DG. Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinson\u2019s disease. 2015;5:1\u201319.","journal-title":"J Parkinson\u2019s disease"},{"key":"3961_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12974-025-03359-w","volume":"22","author":"E Furusawa-Nishii","year":"2025","unstructured":"Furusawa-Nishii E, Solongo B, Rai K, Yoshikawa S, Chiba A, Okuzumi A, et al. alpha-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson\u2019s disease. J Neuroinflamm. 2025;22:38.","journal-title":"J Neuroinflamm"},{"key":"3961_CR61","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/s41467-022-29701-x","volume":"13","author":"S Fleig","year":"2022","unstructured":"Fleig S, Kapanadze T, Bernier-Latmani J, Lill JK, Wyss T, Gamrekelashvili J, et al. Loss of vascular endothelial notch signaling promotes spontaneous formation of tertiary lymphoid structures. Nat Commun. 2022;13:2022.","journal-title":"Nat Commun"},{"key":"3961_CR62","doi-asserted-by":"publisher","unstructured":"Zubkova E, Kalinin A, Beloglazova I, Kurilina E, Menshikov M, Parfyonova Y, et al. Artificial tertiary lymphoid structures: exploring mesenchymal stromal cells as a platform for immune niche formation. Int J Mol Sci. 2024;25(24):13286. https:\/\/doi.org\/10.3390\/ijms252413286.","DOI":"10.3390\/ijms252413286"},{"key":"3961_CR63","doi-asserted-by":"publisher","first-page":"189500","DOI":"10.1016\/j.bbcan.2025.189500","volume":"1880","author":"JY Zhang","year":"2025","unstructured":"Zhang JY, Piao ZY, Su GL, Zhang MJ, Sun ZJ. Tumor-associated high endothelial venules as therapeutic modulation targets in cancer immunotherapy. Biochim et Biophys acta Reviews cancer. 2025;1880:189500.","journal-title":"Biochim et Biophys acta Reviews cancer"},{"key":"3961_CR64","doi-asserted-by":"publisher","first-page":"e70059","DOI":"10.1111\/imr.70059","volume":"334","author":"A Cross","year":"2025","unstructured":"Cross A, Shelley J, Newman R, Strid J, Denton AE. Role of fibroblast-immune crosstalk in kidney, lung, and skin tertiary lymphoid structures. Immunol Rev. 2025;334:e70059.","journal-title":"Immunol Rev"},{"key":"3961_CR65","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","volume":"21","author":"S Davidson","year":"2021","unstructured":"Davidson S, Coles M, Thomas T, Kollias G, Ludewig B, Turley S, et al. Fibroblasts as immune regulators in infection, inflammation and cancer. Nat Rev Immunol. 2021;21:704\u201317.","journal-title":"Nat Rev Immunol"},{"key":"3961_CR66","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","volume":"41","author":"G Vella","year":"2023","unstructured":"Vella G, Hua Y, Bergers G. High endothelial venules in cancer: regulation, function, and therapeutic implication. Cancer Cell. 2023;41:527\u201345.","journal-title":"Cancer Cell"},{"key":"3961_CR67","doi-asserted-by":"publisher","unstructured":"Wang L, Zhang F, Wu J, Yang S, Zhou D, Sun X, et al. Activation and long-term maintenance of adaptive immunity in the central nervous system. A Double-Edged Sword?. CNS Neurosci Ther. 2025;31(12):e70697. https:\/\/doi.org\/10.1002\/cns.70697.","DOI":"10.1002\/cns.70697"},{"key":"3961_CR68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/imr.13124","volume":"311","author":"A Cardani-Boulton","year":"2022","unstructured":"Cardani-Boulton A, Boylan BT, Stetsenko V, Bergmann CC. B cells going viral in the CNS: Dynamics, complexities, and functions of B cells responding to viral encephalitis. Immunol Rev. 2022;311:75\u201389.","journal-title":"Immunol Rev"},{"key":"3961_CR69","doi-asserted-by":"publisher","unstructured":"Gern OL, Mulenge F, Pavlou A, Ghita L, Steffen I, Stangel M, et al. Toll-like receptors in viral encephalitis. Viruses. 2021;13(10):2065. https:\/\/doi.org\/10.3390\/v13102065.","DOI":"10.3390\/v13102065"},{"key":"3961_CR70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00401-023-02537-5","volume":"145","author":"A Agrafiotis","year":"2023","unstructured":"Agrafiotis A, Dizerens R, Vincenti I, Wagner I, Kuhn R, Shlesinger D, et al. Persistent virus-specific and clonally expanded antibody-secreting cells respond to induced self-antigen in the CNS. Acta Neuropathol. 2023;145:335\u201355.","journal-title":"Acta Neuropathol"},{"key":"3961_CR71","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.cell.2021.02.027","volume":"184","author":"P Gonzalez-Figueroa","year":"2021","unstructured":"Gonzalez-Figueroa P, Roco JA, Papa I, Nunez Villacis L, Stanley M, Linterman MA, et al. Follicular regulatory T cells produce neuritin to regulate B cells. Cell. 2021;184:1775\u2013e8919.","journal-title":"Cell"},{"key":"3961_CR72","doi-asserted-by":"publisher","first-page":"101703","DOI":"10.1016\/j.smim.2022.101703","volume":"65","author":"WH Fridman","year":"2023","unstructured":"Fridman WH, Siberil S, Pupier G, Soussan S, Sautes-Fridman C. Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self? Semin Immunol. 2023;65:101703.","journal-title":"Semin Immunol"},{"key":"3961_CR73","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41590-020-0716-3","volume":"21","author":"MA Kovacs","year":"2020","unstructured":"Kovacs MA, Harris TH. Long-\u2018Trm\u2019 protection of the CNS. Nat Immunol. 2020;21:825\u20136.","journal-title":"Nat Immunol"},{"key":"3961_CR74","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41423-024-01181-7","volume":"21","author":"A Pavlou","year":"2024","unstructured":"Pavlou A, Mulenge F, Gern OL, Busker LM, Greimel E, Waltl I, et al. Orchestration of antiviral responses within the infected central nervous system. Cell Mol Immunol. 2024;21:943\u201358.","journal-title":"Cell Mol Immunol"},{"key":"3961_CR75","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman WH, Meylan M, Petitprez F, Sun CM, Italiano A, Sautes-Fridman C. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat reviews Clin Oncol. 2022;19:441\u201357.","journal-title":"Nat reviews Clin Oncol"},{"key":"3961_CR76","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.xcrm.2023.101092","volume":"4","author":"H Lu","year":"2023","unstructured":"Lu H, Lou H, Wengert G, Paudel R, Patel N, Desai S, et al. Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer. Cell Rep Med. 2023;4:101092.","journal-title":"Cell Rep Med"},{"key":"3961_CR77","doi-asserted-by":"publisher","first-page":"933113","DOI":"10.3389\/fcell.2022.933113","volume":"10","author":"A Rossi","year":"2022","unstructured":"Rossi A, Belmonte B, Carnevale S, Liotti A, De Rosa V, Jaillon S, et al. Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses. Front cell Dev biology. 2022;10:933113.","journal-title":"Front cell Dev biology"},{"key":"3961_CR78","doi-asserted-by":"publisher","first-page":"101797","DOI":"10.1016\/j.smim.2023.101797","volume":"69","author":"C Cui","year":"2023","unstructured":"Cui C, Craft J, Joshi NS. T follicular helper cells in cancer, tertiary lymphoid structures, and beyond. Semin Immunol. 2023;69:101797.","journal-title":"Semin Immunol"},{"key":"3961_CR79","doi-asserted-by":"publisher","first-page":"e20518","DOI":"10.1002\/advs.202520518","volume":"13","author":"J Li","year":"2026","unstructured":"Li J, Yang B, Pan T, Zhou X, Ma Z, Tang D, et al. BHLHE40 Orchestrates Effector Tissue-Resident Memory CD8(+) T Cells and Limits Long-Term Survival of Kidney Graft. Adv Sci. 2026;13:e20518.","journal-title":"Adv Sci"},{"key":"3961_CR80","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-immunol-101320-020220","volume":"42","author":"SN Christo","year":"2024","unstructured":"Christo SN, Park SL, Mueller SN, Mackay LK. The Multifaceted Role of Tissue-Resident Memory T Cells. Annu Rev Immunol. 2024;42:317\u201345.","journal-title":"Annu Rev Immunol"},{"key":"3961_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.it.2025.12.006","volume":"47","author":"J Smolders","year":"2026","unstructured":"Smolders J, Hsiao CC, Huitinga I, Hamann J. Resident T cells in the healthy and multiple sclerosis brain. Trends Immunol. 2026;47:297\u2013306.","journal-title":"Trends Immunol"},{"key":"3961_CR82","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.it.2022.10.001","volume":"43","author":"MR Mix","year":"2022","unstructured":"Mix MR, Harty JT. Keeping T cell memories in mind. Trends Immunol. 2022;43:1018\u201331.","journal-title":"Trends Immunol"},{"key":"3961_CR83","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130:1089\u2013104.","journal-title":"Brain"},{"key":"3961_CR84","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3389\/fimmu.2018.01590","volume":"9","author":"S Trend","year":"2018","unstructured":"Trend S, Jones AP, Cha L, Byrne SN, Geldenhuys S, Fabis-Pedrini MJ, et al. Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome. Front Immunol. 2018;9:1590.","journal-title":"Front Immunol"},{"key":"3961_CR85","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011;134:2755\u201371.","journal-title":"Brain"},{"key":"3961_CR86","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","volume":"183","author":"A Jager","year":"2009","unstructured":"Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol. 2009;183:7169\u201377.","journal-title":"J Immunol"},{"key":"3961_CR87","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jnen\/nlw063","volume":"75","author":"B Serafini","year":"2016","unstructured":"Serafini B, Rosicarelli B, Veroni C, Zhou L, Reali C, Aloisi F. RORgammat Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis. J Neuropathol Exp Neurol. 2016;75:877\u201388.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3961_CR88","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1093\/brain\/awt279","volume":"136","author":"C Gardner","year":"2013","unstructured":"Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds R. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats. Brain. 2013;136:3596\u2013608.","journal-title":"Brain"},{"key":"3961_CR89","doi-asserted-by":"publisher","first-page":"e87234","DOI":"10.1172\/jci.insight.87234","volume":"1","author":"K Lehmann-Horn","year":"2016","unstructured":"Lehmann-Horn K, Wang SZ, Sagan SA, Zamvil SS, von Budingen HC. B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. JCI insight. 2016;1:e87234.","journal-title":"JCI insight"},{"key":"3961_CR90","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1474-4422(20)30432-4","volume":"20","author":"G Fadda","year":"2021","unstructured":"Fadda G, Armangue T, Hacohen Y, Chitnis T, Banwell B. Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. Lancet Neurol. 2021;20:136\u201349.","journal-title":"Lancet Neurol"},{"key":"3961_CR91","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/brain\/awae138","volume":"147","author":"J Sun","year":"2024","unstructured":"Sun J, Guo M, Chai L, Xu S, Lizhu Y, Li Y, et al. Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases. Brain. 2024;147:3906\u201317.","journal-title":"Brain"},{"key":"3961_CR92","doi-asserted-by":"publisher","first-page":"105553","DOI":"10.1016\/j.msard.2024.105553","volume":"85","author":"M Leal Rato","year":"2024","unstructured":"Leal Rato M, Chen B, Francis A, Messina S, Miron M, Sharawakanda Y, et al. A study of referral bias in NMOSD and MOGAD cohorts. Multiple Scler Relat disorders. 2024;85:105553.","journal-title":"Multiple Scler Relat disorders"},{"key":"3961_CR93","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.immuni.2021.09.016","volume":"54","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen D, Xu D, Huang C, Xing R, He D, et al. Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges. Immunity. 2021;54:2784\u201394. e6.","journal-title":"Immunity"},{"key":"3961_CR94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pediatrneurol.2024.01.026","volume":"153","author":"A Goldman-Yassen","year":"2024","unstructured":"Goldman-Yassen A, Lee A, Gombolay G. Leptomeningeal Enhancement in Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Antibody Disease, Multiple Sclerosis, and Neuromyelitis Optica Spectrum Disorder. Pediatr Neurol. 2024;153:125\u201330.","journal-title":"Pediatr Neurol"},{"key":"3961_CR95","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138.","journal-title":"Lancet Neurol"},{"key":"3961_CR96","doi-asserted-by":"publisher","first-page":"1204777","DOI":"10.3389\/fimmu.2023.1204777","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, Rajkumar S, Lai Y, Liu X, He J, Ishikawa T, et al. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis. Front Immunol. 2023;14:1204777.","journal-title":"Front Immunol"},{"key":"3961_CR97","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature. 2020;577:399\u2013404.","journal-title":"Nature"},{"key":"3961_CR98","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1038\/s41467-025-62478-3","volume":"16","author":"M Ma","year":"2025","unstructured":"Ma M, Paryani F, Jakubiak K, Xia S, Antoku S, Kannan A, et al. The spatial landscape of glial pathology and T cell response in Parkinson\u2019s disease substantia nigra. Nat Commun. 2025;16:7146.","journal-title":"Nat Commun"},{"key":"3961_CR99","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12974-024-03139-y","volume":"21","author":"P Kettunen","year":"2024","unstructured":"Kettunen P, Koistinaho J, Rolova T. Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review. J Neuroinflamm. 2024;21:152.","journal-title":"J Neuroinflamm"},{"key":"3961_CR100","doi-asserted-by":"publisher","first-page":"1322035","DOI":"10.3389\/fimmu.2023.1322035","volume":"14","author":"Y Dong","year":"2023","unstructured":"Dong Y, Wang T, Wu H. Tertiary lymphoid structures in autoimmune diseases. Front Immunol. 2023;14:1322035.","journal-title":"Front Immunol"},{"key":"3961_CR101","doi-asserted-by":"publisher","unstructured":"Gryka-Marton M, Grabowska AD, Szukiewicz D. Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction. Int J Mol Sci. 2025;26(8):3532. https:\/\/doi.org\/10.3390\/ijms26083532.","DOI":"10.3390\/ijms26083532"},{"key":"3961_CR102","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41467-025-56097-1","volume":"16","author":"SH Yoon","year":"2025","unstructured":"Yoon SH, Kim CY, Lee E, Lee C, Lee KS, Lee J, et al. Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1beta-independent neutrophil chemotaxis upon peripheral inflammation in mice. Nat Commun. 2025;16:699.","journal-title":"Nat Commun"},{"key":"3961_CR103","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/jnnp-2018-319270","volume":"90","author":"F Shimizu","year":"2019","unstructured":"Shimizu F, Oishi M, Sawai S, Beppu M, Misawa S, Matsui N, et al. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy. J Neurol Neurosurg Psychiatry. 2019;90:444\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3961_CR104","doi-asserted-by":"publisher","first-page":"111192","DOI":"10.1016\/j.intimp.2023.111192","volume":"125","author":"AG Vakrakou","year":"2023","unstructured":"Vakrakou AG, Brinia ME, Alexaki A, Koumasopoulos E, Stathopoulos P, Evangelopoulos ME, et al. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice. Int Immunopharmacol. 2023;125:111192.","journal-title":"Int Immunopharmacol"},{"key":"3961_CR105","doi-asserted-by":"publisher","first-page":"763065","DOI":"10.3389\/fimmu.2021.763065","volume":"12","author":"MW Huang","year":"2021","unstructured":"Huang MW, Stock AD, Putterman C. CXCL13 neutralization attenuates neuropsychiatric manifestations in lupus-prone mice. Front Immunol. 2021;12:763065.","journal-title":"Front Immunol"},{"key":"3961_CR106","doi-asserted-by":"publisher","unstructured":"Hsieh CH, Jian CZ, Lin LI, Low GS, Ou PY, Hsu C, et al. Potential role of CXCL13\/CXCR5 signaling in immune checkpoint inhibitor treatment in cancer. Cancers. 2022;14(2):294. https:\/\/doi.org\/10.3390\/cancers14020294.","DOI":"10.3390\/cancers14020294"},{"key":"3961_CR107","doi-asserted-by":"publisher","unstructured":"Hoellwerth M, Koelblinger P, Lang R, Harrer A. Revisiting the role of the CXCL13\/CXCR5-associated immune axis in melanoma: potential implications for anti-PD-1-related biomarker research. Life. 2023;13(2):553. https:\/\/doi.org\/10.3390\/life13020553.","DOI":"10.3390\/life13020553"},{"key":"3961_CR108","doi-asserted-by":"publisher","first-page":"16425","DOI":"10.1038\/s41598-022-19811-3","volume":"12","author":"S Feki","year":"2022","unstructured":"Feki S, Damak M, Sakka S, Ben Ali Y, Mejdoub S, Bouattour N, et al. Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients. Sci Rep. 2022;12:16425.","journal-title":"Sci Rep"},{"key":"3961_CR109","doi-asserted-by":"publisher","unstructured":"Pachner A. The brave new world of early treatment of multiple sclerosis: using the molecular biomarkers CXCL13 and neurofilament light to optimize immunotherapy. Biomedicines. 2022;10(9):2099. https:\/\/doi.org\/10.3390\/biomedicines10092099.","DOI":"10.3390\/biomedicines10092099"},{"key":"3961_CR110","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","volume":"2","author":"L Vanhersecke","year":"2021","unstructured":"Vanhersecke L, Brunet M, Guegan JP, Rey C, Bougouin A, Cousin S, et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat cancer. 2021;2:794\u2013802.","journal-title":"Nat cancer"},{"key":"3961_CR111","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-23-3325","volume":"84","author":"G Petroni","year":"2024","unstructured":"Petroni G, Pillozzi S, Antonuzzo L. Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy. Cancer Res. 2024;84:1199\u2013209.","journal-title":"Cancer Res"},{"key":"3961_CR112","doi-asserted-by":"publisher","unstructured":"Li X, Zhang X, Cao Z, Guan J, Qiu F, Zhang Q, et al. Tertiary lymphoid structures: allies of cancer immunotherapy. Immunology. 2025;24. https:\/\/doi.org\/10.1111\/imm.70020.","DOI":"10.1111\/imm.70020"},{"key":"3961_CR113","doi-asserted-by":"publisher","unstructured":"Vahidian F, Lamaze FC, Bouffard C, Coulombe F, Gagne A, Blais F, et al. CXCL13 positive cells localization predict response to anti-PD-1\/PD-L1 in pulmonary non-small cell carcinoma. Cancers. 2024;16(4):708. https:\/\/doi.org\/10.3390\/cancers16040708.","DOI":"10.3390\/cancers16040708"},{"key":"3961_CR114","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","volume":"28","author":"M Lauss","year":"2022","unstructured":"Lauss M, Donia M, Svane IM, Jonsson G. B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? Clin cancer research: official J Am Association Cancer Res. 2022;28:1751\u20138.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"key":"3961_CR115","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00415-022-11350-1","volume":"270","author":"N Capasso","year":"2023","unstructured":"Capasso N, Palladino R, Cerbone V, Spiezia AL, Covelli B, Fiore A, et al. Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study. J Neurol. 2023;270:272\u201382.","journal-title":"J Neurol"},{"key":"3961_CR116","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s13402-024-00975-1","volume":"47","author":"X Chen","year":"2024","unstructured":"Chen X, Wu P, Liu Z, Li T, Wu J, Zeng Z, et al. Tertiary lymphoid structures and their therapeutic implications in cancer. Cell Oncol. 2024;47:1579\u201392.","journal-title":"Cell Oncol"},{"key":"3961_CR117","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","volume":"25","author":"DH Shu","year":"2024","unstructured":"Shu DH, Ho WJ, Kagohara LT, Girgis A, Shin SM, Danilova L, et al. Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma. Nat Immunol. 2024;25:2110\u201323.","journal-title":"Nat Immunol"},{"key":"3961_CR118","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","volume":"12","author":"L van Hooren","year":"2021","unstructured":"van Hooren L, Vaccaro A, Ramachandran M, Vazaios K, Libard S, van de Walle T, et al. Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma. Nat Commun. 2021;12:4127.","journal-title":"Nat Commun"},{"key":"3961_CR119","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.immuni.2025.09.018","volume":"58","author":"P Cakmak","year":"2025","unstructured":"Cakmak P, Lun JH, Singh A, Macas J, Schupp J, Schuck J, et al. Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. Immunity. 2025;58:2847\u2013e638.","journal-title":"Immunity"},{"key":"3961_CR120","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molmed.2024.10.014","volume":"31","author":"C Yang","year":"2025","unstructured":"Yang C, Cai YX, Wang ZF, Tian SF, Li ZQ. Tertiary lymphoid structures in the central nervous system. Trends Mol Med. 2025;31:509\u201321.","journal-title":"Trends Mol Med"},{"key":"3961_CR121","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cytogfr.2025.12.005","volume":"87","author":"DG Argyris","year":"2026","unstructured":"Argyris DG, Johnson L, Hagglof T, Filippou PS, Karagiannis GS. Emerging involvement of CXCL13 in cancer development and progression. Cytokine Growth Factor Rev. 2026;87:73\u201388.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3961_CR122","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1038\/s41467-025-65421-8","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang G, Zhang X, Liu G, Zhang L, Chen L, et al. Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer. Nat Commun. 2025;16:10435.","journal-title":"Nat Commun"},{"key":"3961_CR123","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1093\/brain\/awac232","volume":"145","author":"RE James Bates","year":"2022","unstructured":"James Bates RE, Browne E, Schalks R, Jacobs H, Tan L, Parekh P, et al. Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration. Brain. 2022;145:4287\u2013307.","journal-title":"Brain"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03961-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:03:25Z","timestamp":1791245005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03961-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3961"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03961-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"334"}}